Slider-home

Infectious Diseases and Immunity in Global Health Program

The Infectious Diseases and Immunity in Global Health Program is integrating research in infectious diseases, immunity and global health at the Research Institute of the McGill University Health Centre (RI-MUHC) into work groups with a strong translational focus.

The translational topics are (i) diagnostics, (ii) therapeutics and prevention and (iii) epidemiology and health outcomes. A distinguishing feature of the program are cross-disciplinary research teams encompassing basic biomedical, clinical and health outcomes research that jointly work on novel ways to improve patient well-being and population health in focus diseases.

Program initiatives are well integrated with ongoing research efforts of other groups at McGill University, as well as national and international centres and organizations dedicated to infectious and immune-mediated diseases. This provides the organizational framework for cutting edge research at the front lines of the most pressing global disease threats by program scientists.

IDIGH Calendar

<<  <  April 2020  >  >>
 Mo  Tu  We  Th  Fr  Sa  Su 
    2  3  4  5
  6  7  9101112
1314161819
202122232526
272830   

Latest IDIGH Publications

  1. Del Corpo, O., Butler-Laporte, G., Sheppard, D. C., Cheng, M. P., McDonald, E. G. & Lee, T. C.
    (2020)
    .
    Diagnostic accuracy of serum (1-3)-β-D-Glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis
    .
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  2. Kuderer, N. M., Choueiri, T. K., Shah, D. P., Shyr, Y., Rubinstein, S. M., Rivera, D. R., Shete, S., Hsu, C.-Y., Desai, A., de Lima Lopes, G., Grivas, P., Painter, C. A., Peters, S., Thompson, M. A., Bakouny, Z., Batist, G., Bekaii-Saab, T., Bilen, M. A., Bouganim, N., Larroya, M. B., Castellano, D., Del Prete, S. A., Doroshow, D. B., Egan, P. C., Elkrief, A., Farmakiotis, D., Flora, D., Galsky, M. D., Glover, M. J., Griffiths, E. A., Gulati, A. P., Gupta, S., Hafez, N., Halfdanarson, T. R., Hawley, J. E., Hsu, E., Kasi, A., Khaki, A. R., Lemmon, C. A., Lewis, C., Logan, B., Masters, T., McKay, R. R., Mesa, R. A., Morgans, A. K., Mulcahy, M. F., Panagiotou, O. A., Peddi, P., Pennell, N. A., Reynolds, K., Rosen, L. R., Rosovsky, R., Salazar, M., Schmidt, A., Shah, S. A., Shaya, J. A., Steinharter, J., Stockerl-Goldstein, K. E., Subbiah, S., Vinh, D. C., Wehbe, F. H., Weissmann, L. B., Wu, J.-T., Wulff-Burchfield, E., Xie, Z., Yeh, A., Yu, P. P., Zhou, A. Y., Zubiri, L., Mishra, S., Lyman, G. H., Rini, B. I., Warner, J. L. & COVID-19 and Cancer Consortium.
    (2020)
    .
    Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
    .
    Lancet (London, England)
  3. Costiniuk, C. T. & Jenabian, M.-A.
    (2020)
    .
    Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
    .
    Cytokine & growth factor reviews
  4. Perera, D., Golizeh, M. & Ndao, M.
    (2020)
    .
    A Procedure for Analyzing the Proteomic Proteomics Profile of Schistosoma mansoni Cercariae
    .
    Methods in molecular biology (Clifton, N.J.)
    ,
    vol
    .
    2151
    ,
    p
    .
    75-84
    .
  5. Mukherjee, M., Forero, D. F., Tran, S., Boulay, M.-E., Bertrand, M., Bhalla, A., Cherukat, J., Al-Hayyan, H., Ayoub, A., Revill, S. D., Javkar, T., Radford, K., Kjarsgaard, M., Huang, C., Dvorkin-Gheva, A., Ask, K., Olivenstein, R., Dendukuri, N., Lemiere, C., Boulet, L.-P., Martin, J. G. & Nair, P.
    (2020)
    .
    Sub-optimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena
    .
    The European respiratory journal
More publications